Corsair Capital Management L.P. Grows Stake in Modular Medical, Inc. (NASDAQ:MODD)

Corsair Capital Management L.P. boosted its holdings in Modular Medical, Inc. (NASDAQ:MODD) by 13.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 537,363 shares of the company’s stock after purchasing an additional 64,393 shares during the quarter. Corsair Capital Management L.P. owned about 1.65% of Modular Medical worth $1,209,000 at the end of the most recent quarter.

Separately, Bard Associates Inc. increased its holdings in Modular Medical by 81.4% during the 3rd quarter. Bard Associates Inc. now owns 1,462,930 shares of the company’s stock valued at $3,292,000 after acquiring an additional 656,330 shares in the last quarter. 27.47% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Modular Medical

In related news, CEO Manchester Management Co Llc purchased 166,666 shares of the business’s stock in a transaction that occurred on Thursday, November 21st. The shares were purchased at an average cost of $1.50 per share, with a total value of $249,999.00. Following the completion of the acquisition, the chief executive officer now directly owns 3,284,743 shares of the company’s stock, valued at approximately $4,927,114.50. The trade was a 5.35 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 32.34% of the company’s stock.

Modular Medical Price Performance

Shares of NASDAQ MODD opened at $1.63 on Wednesday. The company has a 50-day simple moving average of $2.18 and a 200-day simple moving average of $1.85. Modular Medical, Inc. has a 12 month low of $1.08 and a 12 month high of $2.65. The company has a market cap of $56.35 million, a PE ratio of -2.59 and a beta of 0.59.

Modular Medical Profile

Modular Medical, Inc operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.